CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status?

Ho Soo Chun, Minjong Lee

Clin Mol Hepatol. 2021;27(3):448-450. Published online 2021 June 23 DOI: https://doi.org/10.3350/cmh.2021.0130

Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status?

Ho Soo Chun, Minjong Lee

Clinical and Molecular Hepatology. 2021;27(3):448-450

Link1

Link2 Link3

Letter: risk of developing hepatocellular carcinoma in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation. Authors' reply

Gwang Hyeon Choi, Young-Suk Lim

Alimentary Pharmacology & Therapeutics. 2019;50(5):619-620

Link1 Link2

Patterns of hepatitis B viral load level (HBV DNA), hepatitis B e antigen (HBeAg) status and risk factors of cirrhosis and hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients in Thailand

S. Leuangarun, T. Sriprayoon

International Journal of Infectious Diseases. 2012;16:e94

Link1 Link2

E ditorial: hepatitis B DNA thresholds and risk of hepatocellular carcinoma: different number patterns in HBeAg-positive versus HBeAg-negative patients

Geoffrey Dusheiko

Alimentary Pharmacology & Therapeutics. 2020;51(12):1439-1440

Link1 Link2

Editorial: hepatitis B DNA thresholds and risk of hepatocellular carcinoma: different number patterns in HBeAg-positive versus HBeAg-negative patients. Authors' reply

Gi-Ae Kim, Young-Suk Lim

Alimentary Pharmacology & Therapeutics. 2020;51(12):1440-1441

Link1 Link2

Hepatitis B core-related antigen and viral loads status impacts on the risk of hepatocellular carcinoma in patients with HBeAg-negative chronic hepatitis B virus infection

Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, Shunichirou Fujiyama, Yusuke Kawamura, Hitomi Sezaki, Norio Akuta, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Hiromitsu Kumada

Journal of Hepatology. 2020;73:S587

Link1 Link2

O113: Association of the −515A>G CDC6 polymorphism with risk to develop hepatocellular carcinoma in patients with chronic hepatitis C

Journal of Viral Hepatitis. 2014;21:3-4

Link1 Link2 Link3

Goals of Antiviral Therapy for Hepatitis B: HBeAg Seroconversion, HBsAg Seroconversion, Histologic Improvement, and Possible Impact on Risk of Hepatocellular Carcinoma

Petros C. Benias, Albert D. Min

Current Hepatitis Reports. 2011;10(4):292-296

Link1

Link2 Link3

Incidence and risk factors of hepatocellular carcinoma in untreated subjects with chronic hepatitis B virus infection: a systematic review and meta-analysis

E. Raffetti, G. Fattovich, F. Donato

Digestive and Liver Disease. 2015;47:e25

Link1 Link2

P064: Hepatitis B surface Antigen (HBsAg) levels in chronic hepatitis B patients - a comparison between patients of different ages and their hepatitisBeAntigen (HBeAg) seroconversion status in a prospective cohort

Journal of Viral Hepatitis. 2015;22:52-52

Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.